Ozkaya, S. Et Al. 2012. Long-term survival rates of patients with stage IIIB and IV non-small cell lung cancer treated with cisplatin plus vinorelbine or gemcitabine. EXPERIMENTAL AND THERAPEUTIC MEDICINE , vol.4, no.6 , 1035-1038.

Ozkaya, S., Findik, S., Dirican, A., & Atici, A. G., (2012). Long-term survival rates of patients with stage IIIB and IV non-small cell lung cancer treated with cisplatin plus vinorelbine or gemcitabine. EXPERIMENTAL AND THERAPEUTIC MEDICINE , vol.4, no.6, 1035-1038.

Ozkaya, Sevket Et Al. "Long-term survival rates of patients with stage IIIB and IV non-small cell lung cancer treated with cisplatin plus vinorelbine or gemcitabine," EXPERIMENTAL AND THERAPEUTIC MEDICINE , vol.4, no.6, 1035-1038, 2012

Ozkaya, Sevket Et Al. "Long-term survival rates of patients with stage IIIB and IV non-small cell lung cancer treated with cisplatin plus vinorelbine or gemcitabine." EXPERIMENTAL AND THERAPEUTIC MEDICINE , vol.4, no.6, pp.1035-1038, 2012

Ozkaya, S. Et Al. (2012) . "Long-term survival rates of patients with stage IIIB and IV non-small cell lung cancer treated with cisplatin plus vinorelbine or gemcitabine." EXPERIMENTAL AND THERAPEUTIC MEDICINE , vol.4, no.6, pp.1035-1038.

@article{article, author={Sevket Ozkaya Et Al. }, title={Long-term survival rates of patients with stage IIIB and IV non-small cell lung cancer treated with cisplatin plus vinorelbine or gemcitabine}, journal={EXPERIMENTAL AND THERAPEUTIC MEDICINE}, year=2012, pages={1035-1038} }